Evolus (NASDAQ:EOLS) Stock, Quote.Headers.trade-ideas

Evolus

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACON

ARVL

BFRG

CDLX

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CRBP

New Oriental Education & Technology Group

EOLS

LCID

MDAI

MMAT

MNSO

NYXH

ONMD

PALI

PBLA

PRVA

REVB

RVSN

SLNA

SNCE

SOFI

SXTP

VLCN

ZAPP

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering.

Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

CLSK

COIN

LEVI

MARA

MGRC

TARS

WALD

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday.

Shares of  SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue.

SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday

evolus shutter

Analyst Color

Earnings

Health Care

Price Target

Reiteration

Analyst Ratings

General

Evolus beats Q4 revenue expectations, up 40% YoY at $61M. Full-year 2023 hits $202M, exceeding guidance. Analysts bullish on Evolus.

Evolus Set For Promising 2024: Analysts Maintain Positive Outlook On Botox Alternative Maker

Evolus Inc

The Federal Reserve announced Wednesday<a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40926026/federal-reserve-delivers-bold-0-5-rate-cut-signals-further-easing-ahead"> a deep 50 basis-point cut to its Fed funds rate, </a>which is likely to ease the pressure on consumers. An analyst, however, sees a return of recession along with stagnation.
What Happened: &#8220;Get ready for stagnation,&#8221; said GLJ Research&#8217;s Gordon Johnson, adding that, this is the &#8220;inflation is Transitory&#8221; mistake all over again. To make his case, he noted four corporate announcements suggesting the near could be challenging.
China Drags Skechers: Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>), which designs, manufactures and distributes footwear, sees softness in China&#8217;s business. CFO John Vandemore said, at the Wells Fargo Consumer Conference, &#8220;We've definitely seen worse conditions unfold in China than we expected for the back half of the year, so I would expect the back of the year's going to be more disappointing than what we had originally thought.&#8221; The shares reacted with a sharp tumble on Thursday, settling down 9.62% to $61.56
Rough Road For Mercedes-Benz: Also German automaker Mercedes-Benz Group AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MBGAF#OTC">MBGAF</a>) late Thursday said its 2024 earnings before interest and taxes will likely come in &#8220;significantly below&#8221; the previous year, citing a further deterioration in the macroeconomic environment, mainly in China. The automaker also said it expects its adjusted return on sales to be between 7.5% and 8.5%, down from its earlier forecast of 10% to 11%. The company&#8217;s shares listed on the Frankfurt exchange fell nearly 7%.
See Also: <a href="https://www.benzinga.com/money/best-depression-stocks">Best Depression Stocks</a>
FedEx Doesn&#8217;t Deliver: Package-shipping company FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) reported first-quarter earnings that fell year-over-year and missed expectations. The company reduced the high end of the full-year adjusted operating income guidance. The predicament was blamed on circumspect consumers favoring cheaper services over pricey and speedier options. The stock fell over 13% in premarket trading on Friday.
Lennar&#8217;s Underwhelming Quarter: Homebuilder Lennar Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) reported roughly 8% revenue growth to $9.42 billion and earnings per share were up 10% but the average sales price of houses fell.
More Cuts At Warner Music: Entertainment and record-label company Warner Music Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) said Thursday it plans to reduce its workforce by about 750 employees, representing 13% of its total headcount, more than the 10% expected earlier.
R-Word Still Floats Around: Chief Global Strategist of BCA Research Peter Berezin said in an X post that the 50 basis-point cut and another 50 bps reduction the central bank is penciling in before the year-end <a href="https://www.benzinga.com/news/earnings/24/09/40954521/wall-street-looks-to-pause-after-s-ps-record-performance-as-fed-rate-cut-euphoria-fades-and-hard-la">may not ensure a soft landing. </a>He pointed out to the previous two rate-cut cycles when recession followed following 100 basis-point cuts.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), an exchange-traded fund that tracks the S&amp;P 500 Index, fell 0.26% to $567.76, according to <a href="https://benzinga.grsm.io/register174">Benzinga Pro data. </a>The ETF, however, is up nearly 21% so far this year.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40948046/fedex-q1-earnings-revenue-miss-eps-miss-lowered-guidance-challenging-quarter">FedEx Q1 Earnings: Revenue Miss, EPS Miss, Lowered Guidance — &#8216;Challenging Quarter&#8217;</a></li>
</ul>
Image Via Shutterstock

Equities

Economics

MERCEDES BENZ GROUP AG by Mercedes Benz Group AG

MBGAF

Brace For Stagflation After Fed's Benevolence, Warns Analyst, Raising 5 Corporate Red Flags: 'Inflation Is Transitory Mistake All Over Again'

Evercore ISI Group analyst Greg Melich maintains AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) with a Outperform and lowers the price target from $3900 to $3350.

Evercore ISI Group Maintains Outperform on AutoZone, Lowers Price Target to $3350

As of Sept. 20, 2024, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Brooge Energy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BROG#NASDAQ">BROG</a>)</h3>
<ul>
<li>On June 5, Brooge Energy announced the receipt of Nasdaq non-compliance letter. The company's stock gained around 82% over the past month and has a <a href="https://www.benzinga.com/quote/BROG">52-week high of $6.66</a>.</li>
<li>RSI Value: 83.55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>BROG Price Action: Shares of Brooge Energy gained 14.9% to close at $1.77 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Battalion Oil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BATL#NYSE">BATL</a>)</h3>
<ul>
<li>On Sept. 19, Battalion Oil announced it has amended its merger agreement with Fury Resources for the acquisition of all outstanding shares of Battalion at $7.00 per share in cash. Avi Mirman, Co-Founder and Chairman of Fury Resources stated "With this acquisition, Fury has secured a foothold in one of the world&#8217;s most prolific basins. Our team has significant experience in the region, and we believe these assets present a compelling value proposition for our investors. With a deep inventory of high return locations and consolidation opportunities in the area, we believe this asset can be scaled quickly and provide a meaningful return to our investors. We have strong institutional support for this transaction, including the Rollover Stockholders. We view their decision to stay in the investment opportunity as a strong vote of confidence in our ability to deliver results and are excited for us to get to work." The company's stock gained around 17% over the past month and <a href="https://www.benzinga.com/quote/BATL">has a 52-week high</a> of $9.69.</li>
<li>RSI Value: 83.48</li>
<li>BATL Price Action: Shares of Battalion Oil fell 3.6% to close at $2.94 on Thursday. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40952252/nvidia-tesla-rally-as-dow-s-p-500-surge-to-fresh-highs-after-fed-cuts-rates-fear-index-remains-in-g">Nvidia, Tesla Rally As Dow, S&amp;P 500 Surge To Fresh Highs After Fed Cuts Rates: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Short Ideas

Pre-Market Outlook

BATL

BROG

Top 2 Energy Stocks That May Collapse In Q3

The Federal Reserve surprised investors earlier this week by enacting an aggressive 50 basis point cut in benchmark interest rates, marking the first such move since March 2020.
What happened: The dip in borrowing costs immediately boosted risky asset classes like cryptocurrencies, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) spiking 7.7% since the announcement.
The rate was <a href="https://www.federalreserve.gov/newsevents/pressreleases/monetary20200315b.htm">last slashed in an emergency meeting</a> on March 15, 2020, in reaction to the risk posed by the COVID-19 pandemic to the U.S. economy. The federal funds rate was lowered to the range of 0%-0.25%.
At that time, one Bitcoin was priced at $5,392.31. Accordingly, an investment of $1,000 would have fetched you 0.1854 units of the world's largest cryptocurrency. 
Today, the price of one Bitcoin has ballooned to $63,797.59, meaning that 0.1854 BTCs would be worth $11,831.21, marking a whopping 1083% return.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40950912/bitcoins-reserve-asset-appeal-increased-due-to-state-of-us-federal-deficit-and-debt-says-b">Bitcoin&#8217;s Reserve Asset Appeal Increased Due To State Of US Federal Deficit And Debt, Says BlackRock: A Hedge Against &#8216;Possible Future Events&#8217; Affecting The Dollar</a>
Why It Matters: Bitcoin, along with the broader cryptocurrency market, <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40945629/bitcoin-could-surge-after-interest-rate-cut-as-macro-drivers-take-over-standard-chartered">was expected to witness substantial upsides</a> following the bold reduction in interest rates, according to British multinational bank Standard Chartered.
Other noted macro analysts like Alex Kruger have also issued bullish forecasts for the leading cryptocurrency, <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40942948/what-does-the-feds-interest-rate-cut-mean-for-bitcoin-50-bps-cut-is-the-sweet-spot-says-ma">calling the 50-basis point cut a "sweet spot.</a>"
Price Action: At the time of writing, Bitcoin was exchanging hands at $63,731.27, up 2.83% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40951267/max-keiser-attacks-michael-saylor-for-finding-fault-with-el-salvadors-bitcoin-strategy-you">Max Keiser Attacks Michael Saylor For Finding Fault With El Salvador&#8217;s Bitcoin Strategy: &#8216;You Owe Nayib Bukele An Apology&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

If You Invested $1000 in Bitcoin When The Fed Last Cut Interest Rates, Here's How Much It'd Be Worth Today

B of A Securities analyst Ross Fowler reinstates American Water Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>) with a Underperform and announces $140 price target.

Initiation

B of A Securities Reinstates Underperform on American Water Works, Announces $140 Price Target

A new analysis suggests that Bitcoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) correction phase may have come to an end, with experts now predicting a potential <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40926729/bitcoin-spikes-above-61-000-as-fed-implements-50-bps-rate-cut">surge towards the $70,000 mark</a>.
What Happened: According to a 10x Research report, trading signals have increased long positions to 70% net long for the first time, indicating a favorable buying opportunity for both Bitcoin and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) with a 2-3 month horizon.
The report highlights that weekly reversal indicators are showing signs of bottoming out for the first time since the correction began in March, signaling a more positive outlook for the leading cryptocurrency.
Bitcoin&#8217;s weekly Relative Strength Index (RSI) is attempting to establish a medium-term low at 50%, further supporting the bullish sentiment. Key support levels are identified at $52,599 and $56,000, with resistance at $64,490. 
Analysts suggest that a break above the August short-term high of $64,490 could propel Bitcoin toward $70,000 or beyond.
The recent <a href="https://www.benzinga.com/markets/asia/24/09/40951221/bank-of-japan-leaves-interest-rate-at-0-25-diverging-from-feds-50-basis-point-cut">50 basis point rate cut</a> by the Federal Reserve has added an interesting dynamic to the market.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40945847/donald-trump-now-trails-kamala-harris-by-4-points-after-9-point-election-odds-turnaround-i">Donald Trump Now Trails Kamala Harris By 4 Points After 9-Point Election Odds Turnaround In Only 9 Days</a>
While historically, such cuts have led to short-term rallies in Bitcoin, lasting 1-2 weeks, the long-term impact remains to be seen. 
Fed Chair Powell&#8217;s cautious framing of the rate cut has left room for interpretation regarding the broader economic outlook.
Interestingly, funding rates for Bitcoin and Ether have returned to double digits, indicating significant bets from futures traders. 
This renewed momentum is primarily driven by activity in the futures market, with rising trading volumes in Korea suggesting increased participation from retail investors.
What&#8217;s Next: As the cryptocurrency market enters the historically bullish fourth quarter, many eyes will be on Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40945629/bitcoin-could-surge-after-interest-rate-cut-as-macro-drivers-take-over-standard-chartered">Bitcoin Could Surge After Interest Rate Cut As Macro Drivers Take Over: Standard Chartered</a></li>
</ul>

$ETH

Bitcoin's Correction Ends, But It Has To Break This Target To Surge To $70K: 10x Research

B of A Securities analyst Ross Fowler reinstates Essential Utilities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTRG#NYSE">WTRG</a>) with a Buy and announces $45 price target.

WTRG

B of A Securities Reinstates Buy on Essential Utilities, Announces $45 Price Target

WIIM

AEMD

Aethlon Medical shares are trading higher after the company announced that it received granted ethics committee approval for Hemopurifier cancer treatment. Also, the European Commission recommended extending the indication of the smallpox and mpox vaccine to adolescents.

B of A Securities analyst Ross Fowler initiates coverage on SJW Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJW#NYSE">SJW</a>) with a Neutral rating and announces Price Target of $65.

B of A Securities Initiates Coverage On SJW Gr with Neutral Rating, Announces Price Target of $65

Biotech

Large Cap

REGN

The European Medicines Agency's Committee For Medicinal Products For Human Use Adopted A Positive Opinion Recommending The Expanded Approval Of Regeneron Pharmaceuticals/Sanofi's Dupixent (Dupilumab) For Eosinophilic Esophagitis In Children Down To 1 Year Of Age

Arq shares are trading lower after the company announced a proposed public offering of common stock, details not disclosed.

GNFT

GENFIT shares are trading higher. The company reported H1 financial results.

KOPN

Kopin shares are trading lower after the company announced a public offering of common stock and pre-funded warrants, size not disclosed.

Thor Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) will release earnings results for its fiscal 2024 fourth quarter, before the <a href="https://www.benzinga.com/quote/THO/earnings">opening bell on Tuesday, Sept. 24.</a>
Analysts expect the company to report quarterly earnings at $4.83 per share, up from $4.55 per share in the year-ago period. Thor Industries projects to report revenue of $21.99 billion for the quarter, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 19, THOR Industries said its Board of Directors approved the payment of a regular quarterly cash dividend of 48 cents per share.
Thor Industries shares fell 0.5% to close at $188.43 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6531555b0d10db0001eaba63/tristan-thomas-martin">BMO Capital analyst Tristan Thomas-Martin</a> maintained an Outperform rating with a price target of $120 on Sept. 19. This analyst has an accuracy rate of 60%.</li>
<li>Citigroup analyst James Hardiman maintained a Buy rating and slashed the price target from $120 to $113 on June 7. This analyst has an accuracy rate of 68%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58ee65320bd9910001ca9bef/michael-swartz">Truist Securities analyst Michael Swartz</a> maintained a Hold rating and cut the price target from $100 to $95 on June 6. This analyst has an accuracy rate of 70%.</li>
<li>Baird analyst Craig Kennison maintained an Outperform rating and slashed the price target from $120 to $110 on June 6. This analyst has an accuracy rate of 67%.</li>
</ul>
Considering buying THO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="511" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156-1024x511.png" alt="" class="wp-image-557627" style="width:635px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156-1024x511.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156-768x383.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156.png 1326w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40948972/coinbase-global-electronic-arts-and-2-other-stocks-executives-are-selling">Coinbase Global, Electronic Arts And 2 Other Stocks Executives Are Selling</a></li>
</ul>

Thor Industries Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Middlefield Banc</h3>
<ul>
<li>The Trade: Middlefield Banc Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBCN#NASDAQ">MBCN</a>) CEO Ronald Len. Zimmerly Jr <a href="https://www.benzinga.com/quote/ONEW/analyst-ratings">acquired a total of 1,000 shares at</a> an average price of $22.47. To acquire these shares, it cost around $22,470.</li>
<li>What's Happening: On July 18, Middlefield Banc reported quarterly earnings of 52 cents per share which beat the analyst consensus estimate of 40 cents per share.</li>
<li>What Middlefield Banc Does: Middlefield Banc Corp is a United States-based bank holding company.</li>
</ul>

<h3 class="wp-block-heading">Focus Universal</h3>
<ul>
<li>The Trade: Focus Universal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) Director Edward Shihai Lee acquired a total of 1,000,000 shares at an average price of $0.30. To acquire these shares, it cost around $300,000.</li>
<li>What's Happening: On Sept. 16, Focus Universal announced a $1.2 million registered direct offering of 3.75 million shares at $0.32 per share.</li>
<li>What Focus Universal Does: Focus Universal Inc develops and manufactures universal smart devices.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40952252/nvidia-tesla-rally-as-dow-s-p-500-surge-to-fresh-highs-after-fed-cuts-rates-fear-index-remains-in-g">Nvidia, Tesla Rally As Dow, S&amp;P 500 Surge To Fresh Highs After Fed Cuts Rates: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Long Ideas

Insider Trades

FCUV

MBCN

Executives Buying Middlefield Banc And 1 Other Stock

TNON

Tenon Medical shares are trading higher after the company announced the issuance of three notices of allowance for patent applications from the UPSTO.

Battalion Oil Corp shares are trading higher after the company announced it has amended its merger agreement with Fury Resources for the acquisition of all outstanding shares of Battalion at $7.00 per share in cash.

MTDR

Matador Resources Says It Intends To Offer $750M Of Senior Unsecured Notes Due 2033 In A Private Placement To Eligible Purchasers; Company Will Use Net Proceeds From The Offering To Repay Borrowings Outstanding Under Credit Facility

United Parcel Service shares are trading lower in sympathy with FedEx which reported worse-than-expected Q1 financial results and cut its FY25 guidance.

Evercore ISI Group analyst David Palmer upgrades Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) from In-Line to Outperform and raises the price target from $165 to $205.

Upgrades

Evercore ISI Group Upgrades Darden Restaurants to Outperform, Raises Price Target to $205

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Evolus (NASDAQ:<a href="https://investorplace.com/stock-quotes/eols-stock-quote/">EOLS</a>) just reported results for the second quarter of 2024.<ul><li>Evolus reported earnings per share of -4 cents. This was below the analyst estimate for EPS of -3 cents.</li><li>The company reported revenue of $66.91 million.</li><li>This was 1.03% better than the analyst estimate for revenue of $66.23 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/07/eols-stock-earnings-evolus-for-q2-of-2024/">EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024

Evolus, Inc. (EOLS) Q2 2024 Earnings Call Transcript

Evolus Continues To Make Progress

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioNTech SE (BNTX – Research Report), Evolus (EOLS –...

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Evolus (EOLS) and Humana (HUM)

Catalyst Watch: Apple's iPhone event, Oracle earnings, Google antitrust trial, and the August CPI print

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Evolus (EOLS – Research Report), with a price target of $20.00. ...

Barclays Sticks to Their Buy Rating for Evolus (EOLS)

Analyst Serge Belanger of Needham maintained a Buy rating on Evolus (EOLS – Research Report), retaining the price target of $22.00. Serge Belanger ...

Evolus Buy Rating Justified by Strong Market Positioning and Growth Projections

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B...

3 Best Stocks to Buy Now, 9/13/2024, According to Top Analysts

In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Evolus (EOLS – Research Report), with a price target of ...

Stifel Nicolaus Reaffirms Their Buy Rating on Evolus (EOLS)

Leerink Partners analyst Marc Goodman has maintained their bullish stance on EOLS stock, giving a Buy rating on September 13. Marc Goodman's rating...

Evolus's Strategic Growth and Market Expansion Garner a Buy Rating

AAPL

ADBE

AMAT

AURA

BNTX

CART

CHPT

CMPR

COKE

CPRI

CRWD

CTAS

CVGW

DASH

DLTR

ETSY

GILD

GOOG

GOOGL

GTHX

HOOD

INCY

KUASF

LYFT

MANU

MRNA

MSFT

NVDA

OPEN

ORCL

PLAY

RBLX

RBRK

SILK

TTEK

UBER

VITL

WOOF

Press Releases

Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain

Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products

Evolus Announces Appointment of Albert G. White III to Board of Directors

Evolus to Report Second Quarter Financial Results on July 31, 2024

Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference

Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia

Evolus to Hold Investor Day on September 12, 2024

Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Evolus

Evolus (EOLS) Forecast

Evolus (NASDAQ:EOLS) Stock, Quote.Headers.trade-ideas